VIEMED HEALTHCARE, INC.

For the period ended Mar 31, 2025. Filed May 7, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 7, 2025

VMD$8.98+0.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Income

VIEMED HEALTHCARE, INC.CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Expressed in thousands of U.S. Dollars, except share and per share amounts)(Unaudited)

	Three Months Ended March 31,
	Note	2025	2024
Revenue	2	$59,129	$50,593
Cost of revenue		25,850	20,791
Gross profit		$33,279	$29,802
Operating expenses
Selling, general and administrative		28,425	24,814
Research and development		797	750
Stock-based compensation	8	2,311	1,432
Depreciation and amortization		348	415
Loss (gain) on disposal of property and equipment		(2,368)	213
Other income, net		(75)	(26)
Income from operations		$3,841	$2,204
Non-operating income and expenses
Income from investments		—	(67)
Interest expense, net	6	179	150
Net income before taxes		3,662	2,121
Provision for income taxes	10	952	518
Net income		$2,710	$1,603
Net income attributable to noncontrolling interest		85	—
Net income attributable to Viemed Healthcare, Inc.		$2,625	$1,603
Net income per share
Basic	11	$0.07	$0.04
Diluted	11	$0.06	$0.04
Weighted average number of common shares outstanding:
Basic	11	39,426,753	38,717,123
Diluted	11	41,627,876	40,580,634

See accompanying notes to the condensed consolidated financial statements

Page 4

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.